Royalty Pharma Plc Asset Turnover Ratio (RPRX), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Royalty Pharma Plc  (NASDAQ: RPRX)
 

Royalty Pharma Plc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Royalty Pharma Plc's asset turnover ratio, the ratio that measures the ability of Royalty Pharma Plc's assets to generate revenue, sequentially decreased to 0.22 in the third quarter (Sep 30 2026), but it does not raise any concerns as Royalty Pharma Plc continue to execute well, and the asset turnover ratio remains above the average.

Within sector 151 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2026, to 3135, from total ranking in the second quarter 2026 at 3677.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RPRX Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Asset Change 488.84 % 6.21 % 51.11 % 31.68 % 21.44 %
Y / Y Revenue Change 13.26 % 16.5 % 10.97 % 4.78 % 7.9 %
Asset Turnover Ratio (TTM) 0.22 0.32 0.32 0.33 0.33
RPRX's Total Ranking # 3135 # 3677 # 3201 # 3259 # 3311
Seq. Asset Change -1.53 % 461.74 % -3.95 % 10.84 % -82.24 %
Seq. Revenue Change 2.37 % 6.91 % 1.38 % 2.08 % 5.29 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 152
Healthcare Sector # 461
Overall Market # 3135

Asset Turnover Ratio Statistics
High Average Low
0.18 0.08 0
(Dec 31 2020)   (Jun 30 2013)




RPRX Company Profile • Back to RPRX Efficiency Comparisons • Compare RPRX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Aquestive Therapeutics Inc   0.35 $ 48.837  Millions$ 138.245  Millions
Teva Pharmaceutical Industries Limited  0.35 $ 14,020.000  Millions$ 40,171.750  Millions
Profound Medical Corp   0.35 $ 23.627  Millions$ 67.868  Millions
Biogen Inc   0.33 $ 10,297.300  Millions$ 30,765.825  Millions
Krystal Biotech Inc   0.32 $ 470.025  Millions$ 1,454.366  Millions
Hyperfine Inc   0.31 $ 18.537  Millions$ 59.098  Millions
Orasure Technologies Inc  0.31 $ 116.113  Millions$ 373.089  Millions
Pfizer Inc  0.31 $ 63,625.000  Millions$ 205,363.250  Millions
Cardiff Lexington Corporation  0.30 $ 9.066  Millions$ 30.160  Millions
Ionis Pharmaceuticals Inc   0.30 $ 960.091  Millions$ 3,220.224  Millions
Adc Therapeutics Sa  0.30 $ 84.873  Millions$ 287.472  Millions
Sonida Senior Living Inc   0.29 $ 638.130  Millions$ 2,170.454  Millions
Fulgent Genetics Inc   0.29 $ 329.873  Millions$ 1,134.512  Millions
Waters Corporation  0.29 $ 5,611.362  Millions$ 19,618.388  Millions
Orchestra Biomed Holdings Inc   0.28 $ 31.206  Millions$ 109.738  Millions
Amarin Corp Plcuk  0.27 $ 176.609  Millions$ 643.746  Millions
Repligen Corp  0.27 $ 805.610  Millions$ 2,939.265  Millions
Humacyte Inc   0.27 $ 32.703  Millions$ 122.646  Millions
Neogen Corporation  0.26 $ 884.120  Millions$ 3,363.009  Millions
Autolus Therapeutics Plc  0.26 $ 137.434  Millions$ 533.104  Millions
Cryoport inc   0.25 $ 192.439  Millions$ 758.937  Millions
Bio rad Laboratories Inc   0.25 $ 2,593.000  Millions$ 10,350.400  Millions
Revvity Inc  0.25 $ 2,941.761  Millions$ 11,925.295  Millions
Coherus Oncology inc   0.24 $ 53.639  Millions$ 221.663  Millions
Abeona Therapeutics Inc   0.22 $ 41.912  Millions$ 192.374  Millions
Atara Biotherapeutics Inc   0.20 $ 4.019  Millions$ 19.966  Millions
Teleflex Incorporated  0.19 $ 1,283.675  Millions$ 6,716.220  Millions
Elutia Inc   0.18 $ 9.637  Millions$ 52.350  Millions
Maxcyte inc   0.18 $ 34.374  Millions$ 191.034  Millions
Septerna Inc   0.16 $ 96.268  Millions$ 588.004  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.